Higher levels of antimitochondrial antibodies in patients with systemic lupus erythematosus are tied to a higher risk for ...

In this free webinar, gain insight into universal detection strategies for identifying chemical modifications in oligonucleotide therapeutics. Attendees ...

Rapid and reliable virus detection is one of the most critical tools for controlling outbreaks, from seasonal influenza to global pandemics like ...

LNTH READ THE FULL LNTH RESEARCH REPORT As 2026 begins, we are updating investors on Lantheus Holdings, Inc. (NASDAQ:LNTH), ...

Xencor, Inc. , a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced corporate priorities and 2026 pipeline ...

Incregen Therapeutics Advances First-in-Class GIP Ligand Antagonist INC-118 into IND-Enabling Development to Address Long-Term Obesity Management INC-118 directly antagonizes the circulating Glucose ...

Explore MyBioSource's premium PCR kits for disease detection and genetic research, offering fast, accurate results for oncology, infectious diseases, and more.

These promotions recognize attorneys who bring deep legal knowledge and a strong commitment to client service,” said Rob Walat , Wolf Greenfield’s president and managing partner. “Their ability to ...

Sobi vidareutvecklar Gamifant® (emapalumab) vid gammainterferon-driven sepsis (IDS) baserat på topline-data från EMBRACE (2) ...

The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a ...

Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer.

Researchers at the University of Southampton have developed a new antibody design that boosts the immune system’s ability to fight cancer by enhancing activation of T cells through the CD27 receptor.